## GEHC: GE HealthCare Technologies Inc. - XLV: Healthcare

### Executive Summary

No thesis match: MRS_10 0.3% below STRENGTH zone (3.0-6.0%); PEG 2.50 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($79.58)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 3, Bearish: 0)

**1. GE HealthCare Technologies Inc. (NASDAQ:GEHC) is largely controlled by institutional shareholders who own 87% of the company**
- Source: Yahoo Finance | 20260101T120852 | Neutral | Relevance: 100%
- Institutional shareholders collectively own 87% of GE HealthCare Technologies Inc. (NASDAQ:GEHC), indicating that their trading decisions significantly influence the company's stock price. The Vanguard Group, Inc. is the largest shareholder with 11%, and the top 16 shareholders control 51% of the company. Insiders, primarily board members and management, hold less than 1% of the shares, while the general public accounts for a 13% stake.

**2. 1 Healthcare Stock to Target This Week and 2 We Question**
- Source: Finviz | 20251231T233800 | Somewhat-Bearish | Relevance: 100%
- This article analyzes three healthcare stocks: UnitedHealth (UNH) as a strong buy, and GE HealthCare (GEHC) and Avantor (AVTR) as companies to question. It highlights UNH's strong revenue growth, scale, and return on capital, while raising concerns about GEHC's lack of organic growth and declining profitability, and AVTR's underperforming core business and weak demand outlook.

**3. GE HealthCare to supply 300 CT scanners in Indonesia**
- Source: DOTmed | 20251231T132320 | Bullish | Relevance: 100%
- GE HealthCare will supply over 300 CT scanners to public hospitals across Indonesia, as part of the Strengthening Indonesia’s Health Referral Network (SIHREN) program to expand access to advanced diagnostics. This initiative aims to reach 280 million Indonesians, particularly in remote regions, by modernizing the national referral system and improving healthcare infrastructure. The company is also supporting this effort with a new production facility in Bogor and a training hub in Jakarta.

**4. GE HealthCare to supply 300 CT scanners in Indonesia**
- Source: DOTmed | 20251231T130757 | Bullish | Relevance: 100%
- GE HealthCare will supply over 300 CT scanners to public hospitals across all 38 provinces in Indonesia, aiming to expand access to advanced diagnostics for more than 280 million people, including those in remote regions. This initiative is part of the Strengthening Indonesia’s Health Referral Network (SIHREN) program, which is Indonesia’s largest healthcare infrastructure investment. To support this rollout, GE HealthCare has opened a production facility in Bogor and a Regional Innovation & Training Experience Hub in Jakarta to enhance local supply chains, technology transfer, and clinical expertise.

**5. Ethic Inc. Has $2.46 Million Stock Position in GE HealthCare Technologies Inc. $GEHC**
- Source: MarketBeat | 20260101T150740 | Bullish | Relevance: 100%
- Ethic Inc. significantly increased its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 132.3% in the third quarter, now holding 32,759 shares valued at approximately $2.46 million. GE HealthCare has reported strong quarterly earnings, beating estimates, and analysts maintain a "Moderate Buy" rating with an average price target of $87.09. The company also announced a quarterly dividend of $0.035 per share.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 2, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-11 | Citigroup | $88 | $83 | +6% |
| 2025-12-11 | Jefferies | $105 | $95 | +11% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-11 | Citigroup | main | Neutral |
| 2025-12-11 | Jefferies | main | Buy |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 46.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 11.4% (-0.2%)
- Blackrock Inc.: 8.0% (+1.9%)
- Dodge & Cox Inc.: 6.0% (+16.8%)
- Capital Research Glo: 5.5% (+25.0%)
- State Street Corpora: 4.3% (-0.1%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Momentum building: MRS_10 improving +1.4% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 2.50 elevated, pricing in significant growth expectations. Forward P/E 16.8x stretched relative to 8% growth. Quality metrics strong (ROE 24%). Analyst sentiment positive (2 raises, avg +8%). Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $37.8B |
| Beta | 1.24 |
| 52W Range | $57.65 - $94.80 |
| Short Interest | 3.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.50 |
| Forward P/E | 16.8 |
| Current P/E | 18.2 |
| YoY Growth | 8.3% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from -1.0% to 0.3% (+1.4% in 5 days), confirming momentum buildup. Below STRENGTH zone by 2.7pp (needs >3.0% for momentum thesis). MRS_5 at 0.5% confirms short-term momentum alignment. Long-term uptrend intact (above SMA200 at 1.11x) but short-term weakness (below SMA20). RSI neutral at 54. OFD pattern: +SUN (Resistance test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 0.32% (CS: 42) | Neutral |
| RSI_14 | 54.3 | Neutral |
| MACD Histogram | -0.40 | Bearish |
| vs SMA20 | 0.993x | Below |
| vs SMA50 | 1.048x | Above |
| vs SMA200 | 1.112x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $82.82
- **Stop Loss:** $79.58 (3.9% risk)
- **Target:** $86.06 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 444
- **Position Value:** $36,772.08
- **Portfolio %:** 36.77%
- **Risk Dollars:** $1,440.00
- **Risk Per Trade:** 1.44%
- **Modifiers:** L1 120% | L2 120% | Combined 1.44x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.20x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with stable risk appetite as 2026 trading begins. VIX at 14.51 (4th percentile) signals complacency while positive yield curve (+65bps) and moderate breadth (53.1%) support continuation. Focus on upcoming jobs data (Jan 9) and earnings season kickoff mid-January for directional catalysts.*

### Earnings

**Next:** 2026-02-12 (Est: $1.40)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.05 | $1.07 | +2.2% |
| 2025Q2 | $0.92 | $1.06 | +15.4% |
| 2025Q1 | $0.91 | $1.01 | +10.6% |
| 2024Q4 | $1.26 | $1.45 | +14.8% |

---
*RULE-based L3 | 2026-01-06 17:52 | MRS_10*